American Century Companies Inc. Has $135.48 Million Stock Holdings in STERIS plc $STE

American Century Companies Inc. grew its position in STERIS plc (NYSE:STE) by 0.6% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 547,521 shares of the medical equipment provider’s stock after buying an additional 3,136 shares during the period. American Century Companies Inc. owned approximately 0.56% of STERIS worth $135,479,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in STE. Steigerwald Gordon & Koch Inc. bought a new position in STERIS during the third quarter worth about $25,000. Spurstone Advisory Services LLC bought a new stake in shares of STERIS in the second quarter worth about $29,000. Cloud Capital Management LLC acquired a new stake in shares of STERIS during the third quarter worth about $29,000. Geneos Wealth Management Inc. lifted its holdings in shares of STERIS by 416.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 104 shares in the last quarter. Finally, TruNorth Capital Management LLC acquired a new position in shares of STERIS in the 3rd quarter valued at approximately $37,000. Institutional investors own 94.69% of the company’s stock.

STERIS Stock Performance

STE opened at $252.36 on Monday. STERIS plc has a 52-week low of $204.90 and a 52-week high of $269.44. The firm has a market capitalization of $24.75 billion, a PE ratio of 35.20 and a beta of 1.05. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.75 and a current ratio of 2.48. The business’s 50-day simple moving average is $255.83 and its 200 day simple moving average is $251.77.

STERIS (NYSE:STE) last posted its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.53. STERIS had a return on equity of 14.34% and a net margin of 12.15%.During the same period in the prior year, the business earned $2.32 earnings per share. The business’s quarterly revenue was up 9.2% compared to the same quarter last year. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. As a group, sell-side analysts expect that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Tuesday, February 17th will be paid a $0.63 dividend. The ex-dividend date is Tuesday, February 17th. This represents a $2.52 dividend on an annualized basis and a yield of 1.0%. STERIS’s dividend payout ratio (DPR) is currently 35.15%.

Analyst Upgrades and Downgrades

Several brokerages have commented on STE. Wall Street Zen downgraded shares of STERIS from a “strong-buy” rating to a “buy” rating in a report on Saturday, February 14th. Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a report on Friday, January 9th. Six investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $275.20.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.